Guru Ownership Trend
Guru Analysis for Sarepta Therapeutics, Inc. (SRPT)
Sarepta Therapeutics, Inc. (SRPT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $138.37 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $34.01 M net outflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 140.8%. Conversely, Cliff Asness reduced exposure by 32.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Sarepta Therapeutics, Inc. (SRPT)
Major holders include Cliff Asness ($76.87 M), Renaissance Technologies (RenTech) ($20.15 M), HOTCHKIS & WILEY ($10.17 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 7.01 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $34.01 M, with 5 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited SRPT. The total reported sell value was $48.25 M.
Yes, 2 managers opened new positions in SRPT, and 3 increased their existing holdings. The total reported buy value was $14.24 M.
